Table 2.
Summary of clinical outcome of epilepsy patients after using wearable seizure monitoring device.
| Patient # | # of reported seizures by patient/caregiver | # of annotated seizure events | Monitoring device usage time (hours) | Clinical suggestion | Complaints during device use |
|---|---|---|---|---|---|
| Dedicated users | |||||
| 2 | 61 | 43 (24 Generalized, 19 Focal) |
757.9 | Annotation of daily seizure frequency → clinical suggestion to caregiver |
Skin irritations |
| 3 | 53 | 5 (5 Focal) |
233.9 | Annotation of daily seizure frequency → clinical suggestion to caregiver |
Skin irritations, caregiver’s reluctance |
| 6 | 25 | 13 (13 Focal) |
100.4 | Annotation of daily seizure frequency → clinical suggestion to caregiver |
Skin irritations |
| 7 | 24 | 19 (19 Focal) |
108.8 | Identification of ambiguous seizure types → ASM adjustment led to seizure free state |
|
| 8 | 135 | 1,422 (1,422 Focal) |
957.7 | Annotation of daily seizure frequency → clinical suggestion to caregiver |
|
| 10 | 7 | 0 | 110.2 | Ambiguous symptom monitoring → clinical suggestion of non-epileptic events |
Caregiver’s reluctance |
| 12 | 11 | 4 (4 Focal) |
403.0 | Identification of ambiguous seizure types → ASM adjustment led to seizure free state |
|
| 13 | 7 | 0 | 507.3 | Ambiguous symptom monitoring → clinical suggestion of non-epileptic events |
|
| 14 | 287 | 103 (89 Generalized, 14 Focal) |
414.9 | Identification of ambiguous seizure types → ASM adjustment for better seizure control |
|
| Discontinued users | |||||
| 1 | 0 | 0 | 10.4 | Patient’s unwillingness | |
| 4 | 13 | 0 | 3.4 | Skin irritations, caregiver’s reluctance | |
| 5 | 4 | 0 | 5.6 | Patient’s unwillingness | |
| 9 | 7 | 0 | 64.0 | Patient’s unwillingness | |
| 11 | 5 | 0 | 46.6 | Patient’s unwillingness | |